Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Prostate Cancer

  Free Subscription


Articles published in Mod Pathol

Retrieve available abstracts of 28 articles:
HTML format



Single Articles


    June 2021
  1. HANSUM T, Hollemans E, Verhoef EI, Bangma CH, et al
    Comedonecrosis Gleason pattern 5 is associated with worse clinical outcome in operated prostate cancer patients.
    Mod Pathol. 2021 Jun 26. pii: 10.1038/s41379-021-00860.
    PubMed     Abstract available


    March 2021
  2. PERINCHERI S, Levi AW, Celli R, Gershkovich P, et al
    An independent assessment of an artificial intelligence system for prostate cancer detection shows strong diagnostic accuracy.
    Mod Pathol. 2021 Mar 29. pii: 10.1038/s41379-021-00794.
    PubMed     Abstract available


    January 2021
  3. LOTAN TL, Kaur HB, Salles DC, Murali S, et al
    Homologous recombination deficiency (HRD) score in germline BRCA2- versus ATM-altered prostate cancer.
    Mod Pathol. 2021 Jan 18. pii: 10.1038/s41379-020-00731.
    PubMed     Abstract available


    September 2020
  4. HARMON SA, Patel PG, Sanford TH, Caven I, et al
    High throughput assessment of biomarkers in tissue microarrays using artificial intelligence: PTEN loss as a proof-of-principle in multi-center prostate cancer cohorts.
    Mod Pathol. 2020 Sep 3. pii: 10.1038/s41379-020-00674.
    PubMed     Abstract available


    July 2020
  5. HOLLEMANS E, Verhoef EI, Bangma CH, Rietbergen J, et al
    Cribriform architecture in radical prostatectomies predicts oncological outcome in Gleason score 8 prostate cancer patients.
    Mod Pathol. 2020 Jul 20. pii: 10.1038/s41379-020-0625.
    PubMed     Abstract available


    May 2020
  6. RACITI P, Sue J, Ceballos R, Godrich R, et al
    Novel artificial intelligence system increases the detection of prostate cancer in whole slide images of core needle biopsies.
    Mod Pathol. 2020 May 11. pii: 10.1038/s41379-020-0551.
    PubMed     Abstract available


    April 2020
  7. ZHU MMT, Burugu S, Gao D, Yu J, et al
    Evaluation of glucocorticoid-induced TNF receptor (GITR) expression in breast cancer and across multiple tumor types.
    Mod Pathol. 2020 Apr 29. pii: 10.1038/s41379-020-0550.
    PubMed     Abstract available


  8. CHAN E, Garg K, Stohr BA
    Integrated immunohistochemical and molecular analysis improves diagnosis of high-grade carcinoma in the urinary bladder of patients with prior radiation therapy for prostate cancer.
    Mod Pathol. 2020 Apr 20. pii: 10.1038/s41379-020-0543.
    PubMed     Abstract available


  9. DEDIGAMA-ARACHCHIGE P, Carskadon S, Li J, Loveless I, et al
    Clonal evaluation of prostate cancer molecular heterogeneity in biopsy samples by dual immunohistochemistry and dual RNA in situ hybridization.
    Mod Pathol. 2020 Apr 1. pii: 10.1038/s41379-020-0525.
    PubMed     Abstract available


    February 2020
  10. HOLLEMANS E, Verhoef EI, Bangma CH, Rietbergen J, et al
    Clinicopathological characteristics of glomeruloid architecture in prostate cancer.
    Mod Pathol. 2020 Feb 20. pii: 10.1038/s41379-020-0507.
    PubMed     Abstract available


    December 2019
  11. ERSVAER E, Kildal W, Vlatkovic L, Cyll K, et al
    Prognostic value of mitotic checkpoint protein BUB3, cyclin B1, and pituitary tumor-transforming 1 expression in prostate cancer.
    Mod Pathol. 2019 Dec 4. pii: 10.1038/s41379-019-0418.
    PubMed     Abstract available


    November 2019
  12. CAHILL LC, Wu Y, Yoshitake T, Ponchiardi C, et al
    Nonlinear microscopy for detection of prostate cancer: analysis of sensitivity and specificity in radical prostatectomies.
    Mod Pathol. 2019 Nov 19. pii: 10.1038/s41379-019-0408.
    PubMed     Abstract available


    June 2019
  13. MIYAI K, Mikoshi A, Hamabe F, Nakanishi K, et al
    Histological differences in cancer cells, stroma, and luminal spaces strongly correlate with in vivo MRI-detectability of prostate cancer.
    Mod Pathol. 2019 Jun 7. pii: 10.1038/s41379-019-0292.
    PubMed     Abstract available


    April 2019
  14. HAMMARSTEN P, Josefsson A, Thysell E, Lundholm M, et al
    Immunoreactivity for prostate specific antigen and Ki67 differentiates subgroups of prostate cancer related to outcome.
    Mod Pathol. 2019 Apr 12. pii: 10.1038/s41379-019-0260.
    PubMed     Abstract available


  15. KAMMERER-JACQUET SF, Ahmad A, Moller H, Sandu H, et al
    Ki-67 is an independent predictor of prostate cancer death in routine needle biopsy samples: proving utility for routine assessments.
    Mod Pathol. 2019 Apr 11. pii: 10.1038/s41379-019-0268.
    PubMed     Abstract available


    February 2019
  16. VERHOEF EI, van Cappellen WA, Slotman JA, Kremers GJ, et al
    Three-dimensional analysis reveals two major architectural subgroups of prostate cancer growth patterns.
    Mod Pathol. 2019 Feb 8. pii: 10.1038/s41379-019-0221.
    PubMed     Abstract available


    October 2018
  17. HOLLEMANS E, Verhoef EI, Bangma CH, Rietbergen J, et al
    Large cribriform growth pattern identifies ISUP grade 2 prostate cancer at high risk for recurrence and metastasis.
    Mod Pathol. 2018 Oct 22. pii: 10.1038/s41379-018-0157.
    PubMed     Abstract available


    August 2018
  18. BRAMHECHA YM, Rouzbeh S, Guerard KP, Scarlata E, et al
    The combination of PTEN deletion and 16p13.3 gain in prostate cancer provides additional prognostic information in patients treated with radical prostatectomy.
    Mod Pathol. 2018 Aug 23. pii: 10.1038/s41379-018-0107.
    PubMed     Abstract available


    May 2018
  19. KAUR HB, Guedes LB, Lu J, Maldonado L, et al
    Association of tumor-infiltrating T-cell density with molecular subtype, racial ancestry and clinical outcomes in prostate cancer.
    Mod Pathol. 2018 May 30. pii: 10.1038/s41379-018-0083.
    PubMed     Abstract available


    March 2018
  20. TANG Z, Zhang J, Chen H, Lu S, et al
    Reply to Lambros et al.
    Mod Pathol. 2018;31:541-542.
    PubMed    


    January 2018
  21. GRIGNON DJ
    Prostate cancer reporting and staging: needle biopsy and radical prostatectomy specimens.
    Mod Pathol. 2018;31.
    PubMed     Abstract available


  22. EVANS AJ
    Treatment effects in prostate cancer.
    Mod Pathol. 2018;31.
    PubMed     Abstract available


  23. RUBIN MA, Demichelis F
    The Genomics of Prostate Cancer: emerging understanding with technologic advances.
    Mod Pathol. 2018;31.
    PubMed     Abstract available


  24. KRISTIANSEN G
    Markers of clinical utility in the differential diagnosis and prognosis of prostate cancer.
    Mod Pathol. 2018;31.
    PubMed     Abstract available


  25. MAGI-GALLUZZI C
    Prostate cancer: diagnostic criteria and role of immunohistochemistry.
    Mod Pathol. 2018;31.
    PubMed     Abstract available


  26. EPSTEIN JI
    Prostate cancer grading: a decade after the 2005 modified system.
    Mod Pathol. 2018;31.
    PubMed     Abstract available


    October 2017
  27. LI H, Wang Z, Xiao W, Yan L, et al
    Androgen-receptor splice variant-7-positive prostate cancer: a novel molecular subtype with markedly worse androgen-deprivation therapy outcomes in newly diagnosed patients.
    Mod Pathol. 2017 Oct 27. doi: 10.1038/modpathol.2017.
    PubMed     Abstract available


    May 2017
  28. KWELDAM CF, Kummerlin IP, Nieboer D, Steyerberg EW, et al
    Presence of invasive cribriform or intraductal growth at biopsy outperforms percentage grade 4 in predicting outcome of Gleason score 3+4=7 prostate cancer.
    Mod Pathol. 2017 May 19. doi: 10.1038/modpathol.2017.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Prostate Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: